Preferential coxsackievirus replication in proliferating/activated cells: Implications for virus tropism, persistence, and pathogenesis

Current Topics in Microbiology and Immunology

Volumn 323, Issue , 2008, Pages 149-173

  Feuer, R ^a   Whitton, J L ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; VIRUS RECEPTOR; VIRUS RNA;

CELL ACTIVATION; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL MATURATION; CELL PROLIFERATION; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; GENE EXPRESSION; HOST CELL; HUMAN; INTERNAL RIBOSOME ENTRY SITE; LATENT PERIOD; LYMPHOID CELL; NEURAL STEM CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PICORNAVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE CULTURE; VIROGENESIS; VIRUS ENTRY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; ENTEROVIRUS; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; VIROLOGY;

COXSACKIEVIRUS;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; VIRUS REPLICATION;

EID: 43649098718     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-75546-3_7     Document Type: Review

References (126)

1. Andino R, Rieckhof GE, Achacoso PL, Baltimore D (1993) Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. EMBO J 12:3587-3598
2. Archard LC, Bowles NE, Cunningham L, Freeke CA, Olsen EG, Rose ML, Meany B, Why HJ, Richardson PJ (1991) Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur Heart J 12 [Suppl D]:56-59
3. Bjursell G, Skoog L (1980) Control of nucleotide pools in mammalian cells. Antibiot Chemother 28:78-85
4. Bonneau AM, Sonenberg N (1987) Involvement of the 24-kDa cap-binding protein in regulation of protein synthesis in mitosis. J Biol Chem 262:11134-11139
5. Bopegamage S, Kovacova J, Vargova A, Motusova J, Petrovicova A, Benkovicova M, Gomolcak P, Bakkers J, van KF, Melchers WJ, Galama JM (2005) Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol 86:3271-3280
6. Bowles NE, Dubowitz V, Sewry CA, Archard LC (1987) Dermatomyositis, polymyositis, and Coxsackie-B-virus infection. Lancet 1:1004-1007
7. Bowles NE, Rose ML, Taylor P, Banner NR, Morgan-Capner P, Cunningham L, Archard LC, Yacoub MH (1989) End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 80:1128-1136
8. Brenchley JM, Price DA, Douek DC (2006) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7:235-239
9. Brown KE, Anderson SM, Young NS (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114-117
10. Bukrinsky M (2004) A hard way to the nucleus. Mol Med 10:1-5
11. Carthy CM, Granville DJ, Watson KA, Anderson DR, Wilson JE, Yang D, Hunt DW, McManus BM (1998) Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol 72:7669-7675
12. Colbere-Garapin F, Pelletier I, Ouzilou L (2002) Persistent infections by picornaviruses. In: Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. ASM Press, Washington DC, pp 437-448
13. Cornelis S, Bruynooghe Y, Denecker G, van Huffel S, Tinton S, Beyaert R (2000) Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol Cell 5:597-605
14. Creancier L, Morello D, Mercier P, Prats AC (2000) Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulation. J Cell Biol 150:275-281
15. Dalakas MC, Elder G, Hallett M, Ravits J, Baker M, Papadopoulos N, Albrecht P, Sever J (1986) A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med 314:959-963
16. Daley AJ, Isaacs D, Dwyer DE, Gilbert GL (1998) A cluster of cases of neonatal coxsackievirus B meningitis and myocarditis. J Paediatr Child Health 34:196-198
17. Díaz-San Segundo F, Salguero FJ, de Avila A, de Marco MM, Sanchez-Martin MA, Sevilla N (2006) Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J Virol 80:2369-2379
18. Douche-Aourik F, Berlier W, Feasson L, Bourlet T, Harrath R, Omar S, Grattard F, Denis C, Pozzetto B (2003) Detection of enterovirus in human skeletal muscle from patients with chronic inflammatory muscle disease or fibromyalgia and healthy subjects. J Med Virol 71:540-547
19. Dunn JJ, Chapman NM, Tracy S, Romero JR (2000) Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5′ nontranslated region. J Virol 74:4787-4794
20. Elford HL (1972) Functional regulation of mammalian ribonucleotide reductase. Adv Enzyme Regul 10:19-38
21. Eremenko T, Benedetto A, Volpe P (1972a) Poliovirus replication during HeLa cell life cycle. Nat New Biol 237:114-116
22. Eremenko T, Benedetto A, Volpe P (1972b) Virus infection as a function of the host cell life cycle: replication of poliovirus RNA. J Gen Virol 16:61-68
23. Euscher E, Davis J, Holzman I, Nuovo GJ (2001) Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet Gynecol 98:1019-1026
24. Evans DM, Dunn G, Minor PD, Schild GC, Cann AJ, Stanway G, Almond JW, Currey K, Maizel JV Jr (1985) Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 polio vaccine genome. Nature 314:548-550
25. Feuer R, Mena I, Pagarigan RR, Slifka MK, Whitton JL (2002) Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 76:4430-4440
26. Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL (2003) Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 163:1379-1393
27. Feuer R, Mena I, Pagarigan RR, Hassett DE, Whitton JL (2004) Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency. Med Microbiol Immunol (Berl) 193:83-90
28. Feuer R, Pagarigan RR, Harkins S, Liu F, Hunziker IP, Whitton JL (2005) Coxsackievirus targets proliferating neuronal progenitor cells in the neonatal CNS. J Neurosci 25:2434-2444
29. Fritsch EF, Temin HM (1977) Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses. J Virol 24:461-469
30. Galbraith DN, Nairn C, Clements GB (1995) Phylogenetic analysis of short enteroviral sequences from patients with chronic fatigue syndrome. J Gen Virol 76:1701-1707
31. Giraud S, Greco A, Brink M, Diaz JJ, Delafontaine P (2001) Translation initiation of the insulin-like growth factor I receptor mRNA is mediated by an internal ribosome entry site. J Biol Chem 276:5668-5675
32. Harrath R, Bourlet T, Delezay O, Douche-Aourik F, Omar S, Aouni M, Pozzetto B (2004) Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line. J Med Virol 74:283-290
33. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP (2000) A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci U S A 97:13871-13876
34. Hassett DE, Zhang J, Whitton JL (1997) Neonatal DNA immunization with an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J Virol 71:7881-7888
35. Hellen CU, Sarnow P (2001) Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 15:1593-1612
36. Helt AM, Harris E (2005) S-phase-dependent enhancement of dengue virus 2 replication in mosquito cells, but not in human cells. J Virol 79:13218-13230
37. Henke A, Launhardt H, Klement K, Stelzner A, Zell R, Munder T (2000) Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol 74:4284-4290
38. Hogle JM (2002) Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol 56:677-702
39. Honda M, Kaneko S, Matsushita E, Kobayashi K, Abell GA, Lemon SM (2000) Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 118:152-162
40. Hsueh C, Jung SM, Shih SR, Kuo TT, Shieh WJ, Zaki S, Lin TY, Chang LY, Ning HC, Yen DC (2000) Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan: report of an autopsy case with pathologic, immunofluorescence, and molecular studies. Mod Pathol 13:1200-1205
41. Huber SA (2006) Autoimmunity in coxsackievirus B3 induced myocarditis. Autoimmunity 39:55-61
42. Humphries EH, Temin HM (1974) Requirement for cell division for initiation of transcription of Rous sarcoma virus RNA. J Virol 14:531-546
43. Hunziker IP, Cornell CT, Whitton JL (2006) Deletions within the 5′UTR of coxsackievirus B3: consequences for virus translation and replication. Virology 360:120-128
44. Illinger D, Italiano L, Beck JP, Waltzinger C, Kuhry JG (1993) Comparative evolution of endocytosis levels and of the cell surface area during the L929 cell cycle: a fluorescence study with TMA-DPH. Biol Cell 79:265-268
45. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577-1581
46. Julien J, Leparc-Goffart I, Lina B, Fuchs F, Foray S, Janatova I, Aymard M, Kopecka H (1999) Postpolio syndrome: poliovirus persistence is involved in the pathogenesis. J Neurol 246:472-476
47. Kaplan MH, Klein SW, McPhee J, Harper RG (1983) Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 5:1019-1032
48. Kauder SE, Racaniello VR (2004) Poliovirus tropism and attenuation are determined after internal ribosome entry. J Clin Invest 113:1743-1753
49. Kim KS, Tracy S, Tapprich W, Bailey J, Lee CK, Kim K, Barry WH, Chapman NM (2005) 5′-terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol 79:7024-7041
50. Klingel K, Stephan S, Sauter M, Zell R, McManus BM, Bultmann B, Kandolf R (1996) Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J Virol 70:8888-8895
51. Koch AS, Eremenko T, Benedetto A, Volpe P (1974) A guanidine-sensitive step of the poliovirus RNA replication cycle. Intervirology 4:221-225
52. Kusov YY, Gosert R, Gauss-Muller V (2005) Replication and in vivo repair of the hepatitis A virus genome lacking the poly(A) tail. J Gen Virol 86:1363-1368
53. Lake RS, Winkler DC, Ludwig EH (1970) Delay of mengovirus-induced cytopathology in mitotic L-cells. J Virol 5:262-263
54. Leon-Monzon ME, Dalakas MC (1995) Detection of poliovirus antibodies and poliovirus genome in patients with the post-polio syndrome. Ann N Y Acad Sci 753:208-218
55. Leparc-Goffart I, Julien J, Fuchs F, Janatova I, Aymard M, Kopecka H (1996) Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome. J Clin Microbiol 34:2023-2026
56. Levi G, Scalvini S, Volterrani M, Marangoni S, Arosio G, Quadri A (1988) Coxsackie virus heart disease: 15 years after. Eur Heart J 9:1303-1307
57. Liu P, Aitken K, Kong YY, Opavsky MA, Martino T, Dawood F, Wen WH, Kozieradzki I, Bachmaier K, Straus D, Mak TW, Penninger JM (2000) The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nat Med 6:429-434
58. Madshus IH, Olsnes S, Sandvig K (1984) Requirements for entry of poliovirus RNA into cells at low pH. EMBO J 3:1945-1950
59. Mallucci L, Wells V, Beare D (1985) Cell cycle position and expression of encephalomyocarditis virus in mouse embryo fibroblasts. J Gen Virol 66:1501-1506
60. Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL (2003a) The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115:449-459
61. Manel N, Kinet S, Battini JL, Kim FJ, Taylor N, Sitbon M (2003a) The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis. Blood 101:1913-1918
62. Marcus PI, Robbins E (1963) Viral inhibition in the metaphase-arrest cell. Proc Natl Acad Sci U S A 50:1156-1164
63. Martin J, Odoom K, Tuite G, Dunn G, Hopewell N, Cooper G, Fitzharris C, Butler K, Hall WW, Minor PD (2004) Long-term excretion of vaccine-derived poliovirus by a healthy child. J Virol 78:13839-13847
64. Martinez X, Brandt C, Saddallah F, Tougne C, Barrios C, Wild F, Dougan G, Lambert PH, Siegrist CA (1997) DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc Natl Acad Sci U S A 94:8726-8731
65. Martino TA, Liu P, Petric M, Sole MJ (1995) Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. 291-351
66. Mazze FM, Degreve L (2006) The role of viral and cellular proteins in the budding of human immunodeficiency virus. Acta Virol 50:75-85
67. Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard JR, Whitton JL (1999) The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol 155:1205-1215
68. Metskula K, Salur L, Mandel M, Uibo R (2006) Demonstration of high prevalence of SS-A antibodies in a general population: association with HLA-DR and enterovirus antibodies. Immunol Lett 106:14-18
69. Minor PD, Dunn G (1988) The effect of sequences in the 5′ non-coding region on the replication of polioviruses in the human gut. J Gen Virol 69:1091-1096
70. Modlin JF (1988) Perinatal echovirus and group B coxsackievirus infections. Clin Perinatol 15:233-246
71. Modlin JF, Bowman M (1987) Perinatal transmission of coxsackievirus B3 in mice. J Infect Dis 156:21-25
72. Molla A, Paul AV, Wimmer E (1991) Cell-free, de novo synthesis of poliovirus. Science 254:1647-1651
73. Muir P, Nicholson F, Sharief MK, Thompson EJ, Cairns NJ, Lantos P, Spencer GT, Kaminski HJ, Banatvala JE (1995) Evidence for persistent enterovirus infection of the central nervous system in patients with previous paralytic poliomyelitis. Ann N Y Acad Sci 753:219-232
74. Muszynski KW, Thompson D, Hanson C, Lyons R, Spadaccini A, Ruscetti SK (2000) Growth factor-independent proliferation of erythroid cells infected with Friend spleen focus-forming virus is protein kinase C dependent but does not require Ras-GTP. J Virol 74:8444-8451
75. Nair V, Zavolan M (2006) Virus-encoded microRNAs: novel regulators of gene expression. Trends Microbiol 14:169-175
76. Naniche D, Oldstone MB (2000) Generalized immunosuppression: how viruses undermine the immune response. Cell Mol Life Sci 57:1399-1407
77. Naniche D, Reed SI, Oldstone MBA (1999) Cell cycle arrest during measles virus infection: a G0-like block leads to suppression of retinoblastoma protein expression. J Virol 73:1894-1901
78. Nelson HB, Tang H (2006) Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression. J Virol 80:1181-1190
79. Oleksiewicz MB, Alexandersen S (1997) S-phase-dependent cell cycle disturbances caused by Aleutian mink disease parvovirus. J Virol 71:1386-1396
80. Op De Beeck A, Caillet-Fauquet P (1997) Viruses and the cell cycle. Prog Cell Cycle Res 3:1-19
81. Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C, Petric M, Trinidad C, Butcher L, Chan J, Liu PP (2002) Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 109:1561-1569
82. Patnaik A, Chau V, Wills JW (2000) Ubiquitin is part of the retrovirus budding machinery. Proc Natl Acad Sci U S A 97:13069-13074
83. Pilipenko EV, Pestova TV, Kolupaeva VG, Khitrina EV, Poperechnaya AN, Agol VI, Hellen CU (2000) A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev 14:2028-2045
84. Poggioli GJ, Keefer C, Connolly JL, Dermody TS, Tyler KL (2000) Reovirus-induced G2/M cell cycle arrest requires sigma1s and occurs in the absence of apoptosis. J Virol 74:9562-9570
85. Poon B, Grovit-Ferbas K, Stewart SA, Chen IS (1998) Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science 281:266-269
86. Pyronnet S, Sonenberg N (2001) Cell-cycle-dependent translational control. Curr Opin Genet Dev 11:13-18
87. Pyronnet S, Pradayrol L, Sonenberg N (2000) A cell cycle-dependent internal ribosome entry site. Mol Cell 5:607-616
88. Qin X, Sarnow P (2004) Preferential translation of internal ribosome entry site-containing mRNAs during the mitotic cycle in mammalian cells. J Biol Chem 279:13721-13728
89. Rall GF (2003) Measles virus 1998-2002: progress and controversy. Annu Rev Microbiol 57:343-367
90. Ramirez JC, Fairen A, Almendral JM (1996) Parvovirus minute virus of mice strain I multiplication and pathogenesis in the newborn mouse brain are restricted to proliferative areas and to migratory cerebellar young neurons. J Virol 70:8109-8116
91. Rantakallio P, Jones P, Moring J, von Wendt L (1997) Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int J Epidemiol 26:837-843
92. Ratzan KR (1985) Viral meningitis. Med Clin North Am 69:399-413
93. Ridge JP, Fuchs EJ, Matzinger P (1996) Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723-1726
94. Rodriguez M, Oleszak E, Leibowitz J (1987) Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol 7:325-365
95. Salt JS (1998) Persistent infection with foot-and-mouth disease virus. Top Trop Virol 1:77-129
96. Satake K, Kimura K, Saito T (1999) Therapeutic effects of loxiglumide on experimental acute pancreatitis using various models. Digestion 60 [Suppl 1]:64-68
97. Sauerbrei A, Gluck B, Jung K, Bittrich H, Wutzler P (2000) Congenital skin lesions caused by intrauterine infection with coxsackievirus B3. Infection 28:326-328
98. Scholle F, Li K, Bodola F, Ikeda M, Luxon BA, Lemon SM (2004) Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis. J Virol 78:1513-1524
99. Seidman MA, Hogan SM, Wendland RL, Worgall S, Crystal RG, Leopold PL (2001) Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle. Mol Ther 4:13-21
100. Shapiro-Shelef M, Calame K (2005) Regulation of plasma-cell development. Nat Rev Immunol 5:230-242
101. Shaw-Jackson C, Michiels T (1997) Infection of macrophages by Theiler's murine encephalomyelitis virus is highly dependent on their activation or differentiation state. J Virol 71:8864-8867
102. Shiroki K, Ishii T, Aoki T, Ota Y, Yang WX, Komatsu T, Ami Y, Arita M, Abe S, Hashizume S, Nomoto A (1997) Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA. J Virol 71:1-8
103. Srivastava D, Ivey KN (2006) Potential of stem-cell-based therapies for heart disease. Nature 441:1097-1099
104. Suarez M, Contreras G, Fridlender B (1975) Multiplication of Coxsackie B1 virus in synchronized HeLa cells. J Virol 16:1337-1339
105. Swanton C, Jones N (2001) Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products. Int J Exp Pathol 82:3-13
106. Talbot SJ, Crawford DH (2004) Viruses and tumours-an update. Eur J Cancer 40:1998-2005
107. Tam PE (2006) Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol 19:133-146
108. Tam PE, Messner RP (1999) Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol 73:10113-10121
109. Tam PE, Schmidt AM, Ytterberg SR, Messner RP (1991) Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis. J Virol 65:6654-6660
110. Tam PE, Schmidt AM, Ytterberg SR, Messner RP (1994) Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis. J Lab Clin Med 123:346-356
111. Triantafilou K, Orthopoulos G, Vakakis E, Ahmed MA, Golenbock DT, Lepper PM, Triantafilou M (2005) Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol 7:1117-1126
112. Triantafyllopoulou A, Tapinos N, Moutsopoulos HM (2004) Evidence for coxsackievirus infection in primary Sjögren's syndrome. Arthritis Rheum 50:2897-2902
113. Tuthill TJ, Bubeck D, Rowlands DJ, Hogle JM (2006) Characterization of early steps in the poliovirus infection process: receptor-decorated liposomes induce conversion of the virus to membrane-anchored entry-intermediate particles. J Virol 80:172-180
114. Urata S, Noda T, Kawaoka Y, Yokosawa H, Yasuda J (2006) Cellular factors required for Lassa virus budding. J Virol 80:4191-4195
115. Van Ooij MJ, Polacek C, Glaudemans DH, Kuijpers J, van Kuppeveld FJ, Andino R, Agol VI, Melchers WJ (2006a) Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element. Nucleic Acids Res 34:2953-2965
116. Van Ooij MJ, Vogt DA, Paul A, Castro C, Kuijpers J, van Kuppeveld FJ, Cameron CE, Wimmer E, Andino R, Melchers WJ (2006b) Structural and functional characterization of the coxsackievirus B3 CRE(2C): role of CRE(2C) in negative- and positive-strand RNA synthesis. J Gen Virol 87:103-113
117. Venkatesan A, Sharma R, Dasgupta A (2003) Cell cycle regulation of hepatitis C and encephalomyocarditis virus internal ribosome entry site-mediated translation in human embryonic kidney 293 cells. Virus Res 94:85-95
118. Verschuren EW, Jones N, Evan GI (2004) The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin. J Gen Virol 85:1347-1361
119. Watts AM, Stanley JR, Shearer MH, Hefty PS, Kennedy RC (1999) Fetal immunization of baboons induces a fetal-specific antibody response. Nat Med 5:427-430
120. Wells A, Steen HB, Godal T, Klein G (1981) Epstein-Barr virus receptor expression is correlated to cell cycle phase. J Recept Res 2:285-298
121. Wessely R, Klingel K, Knowlton KU, Kandolf R (2001) Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 103:756-761
122. Wirblich C, Bhattacharya B, Roy P (2006) Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101. J Virol 80:460-473
123. Woodall CJ, Graham DI (2004) Evidence for neuronal localisation of enteroviral sequences in motor neurone disease/amyotrophic lateral sclerosis by in situ hybridization. Eur J Histochem 48:129-134
124. Woodall CJ, Riding MH, Graham DI, Clements GB (1994) Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease. BMJ 308:1541-1543
125. Yin J, Paul AV, Wimmer E, Rieder E (2003) Functional dissection of a poliovirus cis-acting replication element [PV-cre(2C)]: analysis of single- and dual-cre viral genomes and proteins that bind specifically to PV-cre RNA. J Virol 77:5152-5166
126. Young NS, Brown KE (2004) Parvovirus B19. N Engl J Med 350:586-597